Photo by jxk from unsplash
for to pre-exposition neutralizing casirivimab and imdevimab monoclonal antibodies in immunosuppressed patients with no or weak response to three doses of SARS-CoV-2 Click to show full abstract
for to pre-exposition neutralizing casirivimab and imdevimab monoclonal antibodies in immunosuppressed patients with no or weak response to three doses of SARS-CoV-2
Keywords:
pre exposition;
casirivimab imdevimab;
omicron breakthrough;
monoclonal antibodies;
imdevimab monoclonal
Journal Title: Transplant Infectious Disease
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transplant Infectious Disease
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!